Search results for: 'system low its'

With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...

Digital biomarkers play a crucial role in early disease detection and prevention; data-driven insights generated by wearable support early diagnosis, real-time monitoring of patient health, precise healthcare delivery, remote patient monitoring, and advanced R&D effort in the treatment of neurodegenerative conditions. While innovation focuses on th...

According to the World Health Organization, at least half of the world’s population do not have access to essential health services due to the high healthcare costs. Frugal medical device innovations can improve the healthcare accessibility and quality of care to the people, especially those at lower socio-economic status. This research service (RS...

19 Feb 2021  |  North America  |  Market Research

Regulatory and Infrastructure Reforms in India and China Catalyzing the Asian Specialty Generics Market

High Unmet Needs in Niche Oncology Indications will Drive Future Growth Potential

Infographics

×

Frost & Sullivans Transformational Health team provides critical insights into the Asian specialty generics market with this research service, highlighting growth opportunities, selected countries biopharmaceutical environment, and significant R&D, regulatory, and infrastructure reforms influencing its growth. The report examines similarities and c...

There is a growing demand for mobile imaging equipment in low and middle-income countries due to the limited financial resources to procure, operate, and maintain expensive medical imaging equipment. Other challenges include irregular power supply, poor network connectivity, inadequate site infrastructure, and delays because of the geographical dis...

25 Mar 2022  |  North America  |  Frost Radar

Frost Radar™: North American Clinical Documentation Improvement Market, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Clinical documentation improvement (CDI), a vital mechanism in documenting care in the healthcare space, is a strategic necessity that goes beyond a component in the broader revenue cycle management (RCM) of claims processing. It focuses on improved patient outcomes, supports data quality that tells an accurate story of the patient’s care, facilita...

This Frost Radar benchmarks companies offering digital pathology solutions for hospitals and laboratories and discusses opportunities in clinical, pharma, CRO, and research applications. Digital pathology solutions cover all aspects of workflow including sample collection and preparation, image acquisition and integrated image storage, and anal...

15 Dec 2020  |  Global  |  Frost Radar

Frost Radar™: Advanced Antibodies, 2020

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

Infographics

×

With advances in antibody-based therapies, bispecific antibodies (bsAbs) have gained momentum in the last few years after the regulatory approvals of Amgens blinatumomab (Blincyto®) and Chugais Hemlibra for Hemophilia A. The key advantage of bsAbs lies in their ability to bind two different epitopes or antigens, thereby overcoming the limitations o...

The healthcare industry is undergoing a data revolution, and analytics is at the heart of it. This Frost Radar will reveal the strategies, technologies, and innovations that are shaping the industry and driving success. By understanding the current landscape, digital health readers can stay ahead of the curve, identify emerging trends, and make in...